Vanguard Group’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $105M | Sell |
4,238,192
-482,884
| -10% | -$12.8M | ﹤0.01% | 1851 |
|
|
2025
Q3 | $134M | Sell |
4,721,076
-112,308
| -2% | -$3.04M | ﹤0.01% | 1730 |
|
|
2025
Q2 | $120M | Sell |
4,833,384
-65,608
| -1% | -$1.85M | ﹤0.01% | 1746 |
|
|
2025
Q1 | $152M | Buy |
4,898,992
+213,033
| +5% | +$7.1M | ﹤0.01% | 1607 |
|
|
2024
Q4 | $148M | Buy |
4,685,959
+20,757
| +0.4% | +$986K | ﹤0.01% | 1678 |
|
|
2024
Q3 | $270M | Sell |
4,665,202
-52,885
| -1% | -$2.6M | ﹤0.01% | 1378 |
|
|
2024
Q2 | $191M | Sell |
4,718,087
-342,123
| -7% | -$13.6M | ﹤0.01% | 1515 |
|
|
2024
Q1 | $212M | Buy |
5,060,210
+10,282
| +0.2% | +$401K | ﹤0.01% | 1477 |
|
|
2023
Q4 | $193M | Buy |
5,049,928
+260,687
| +5% | +$8.68M | ﹤0.01% | 1523 |
|
|
2023
Q3 | $148M | Buy |
4,789,241
+43,714
| +0.9% | +$1.51M | ﹤0.01% | 1592 |
|
|
2023
Q2 | $150M | Buy |
4,745,527
+32,257
| +0.7% | +$1.11M | ﹤0.01% | 1623 |
|
|
2023
Q1 | $172M | Buy |
4,713,270
+274,315
| +6% | +$9.6M | ﹤0.01% | 1531 |
|
|
2022
Q4 | $131M | Buy |
4,438,955
+172,563
| +4% | +$5.55M | ﹤0.01% | 1649 |
|
|
2022
Q3 | $166M | Buy |
4,266,392
+66,735
| +2% | +$3.05M | ﹤0.01% | 1498 |
|
|
2022
Q2 | $162M | Buy |
4,199,657
+273,681
| +7% | +$10.4M | ﹤0.01% | 1557 |
|
|
2022
Q1 | $190M | Buy |
3,925,976
+28,661
| +0.7% | +$1.48M | ﹤0.01% | 1586 |
|
|
2021
Q4 | $286M | Buy |
3,897,315
+750,357
| +24% | +$61.6M | 0.01% | 1379 |
|
|
2021
Q3 | $287M | Buy |
3,146,958
+1,410,547
| +81% | +$120M | 0.01% | 1356 |
|
|
2021
Q2 | $109M | Buy |
1,736,411
+463,617
| +36% | +$17.1M | ﹤0.01% | 1957 |
|
|
2021
Q1 | $34.5M | Buy |
1,272,794
+19,007
| +2% | +$457K | ﹤0.01% | 2507 |
|
|
2020
Q4 | $22.9M | Buy |
1,253,787
+45,626
| +4% | +$820K | ﹤0.01% | 2567 |
|
|
2020
Q3 | $21.7M | Sell |
1,208,161
-149,231
| -11% | -$2.57M | ﹤0.01% | 2417 |
|
|
2020
Q2 | $22.4M | Buy |
1,357,392
+590,536
| +77% | +$9.29M | ﹤0.01% | 2363 |
|
|
2020
Q1 | $9.91M | Sell |
766,856
-101,830
| -12% | -$1.66M | ﹤0.01% | 2633 |
|
|
2019
Q4 | $16M | Sell |
868,686
-405,969
| -32% | -$6.73M | ﹤0.01% | 2636 |
|
|
2019
Q3 | $22.5M | Buy |
1,274,655
+109,828
| +9% | +$1.88M | ﹤0.01% | 2432 |
|
|
2019
Q2 | $19.5M | Buy |
1,164,827
+102,267
| +10% | +$1.86M | ﹤0.01% | 2523 |
|
|
2019
Q1 | $19.5M | Buy |
1,062,560
+97,380
| +10% | +$1.87M | ﹤0.01% | 2519 |
|
|
2018
Q4 | $19.2M | Buy |
965,180
+36,269
| +4% | +$679K | ﹤0.01% | 2461 |
|
|
2018
Q3 | $20.5M | Buy |
928,911
+602,710
| +185% | +$12.7M | ﹤0.01% | 2566 |
|
|
2018
Q2 | $8.44M | Buy |
+326,201
| New | +$5.59M | ﹤0.01% | 2986 |
|
Other funds holding ASTH
3C
SW
